Mr Spyridon Mourtzoukos

Mr Spyridon Mourtzoukos is a highly experienced consultant ophthalmologist in Worthing, who specialises in diabetic retinopathy, cataracts and AMD, alongside surgical retina, external eye disease, simple glaucoma and intravitreal treatments. He privately practises at Goring Hall hospital - part of Circle Health Group, while his NHS base is Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, where he is Deputy Lead in Diabetic Ophthalmology and Diabetic Screening, taking responsibility for the Diabetic Macular Oedema service.

Mr Mourtzoukos graduated from Athens Medical School in 1997 and completed his training in general Ophthalmology at the Red Cross General Hospital in Athens in 2007. He holds the Fellowship of the European Board of Ophthalmology (FEBOphth), demonstrating recognition at the European level, and is a registered member of the Royal College of Ophthalmologists.

He gained surgical retina experience at Hallamshire Hospital in Sheffield between 2008 and 2011, followed by medical retina training at Southampton University Hospital from 2012 to 2013. He was subsequently appointed at his NHS trust.

Mr Mourtzoukos offers a comprehensive range of ophthalmology services covering several key areas. His expertise includes cataract surgery with options for monofocal, multifocal, and toric lenses tailored to individual visual needs. Additionally, he provides assessment and management for glaucoma, including YAG laser and Selective Laser Trabeculoplasty (SLT) treatments, and administers intravitreal injections for various retinal conditions. Other procedures include the removal of cystic lesions from the eyelid.

Mr Mourtzoukos is actively involved in education and research. Since 2018, he has served as a College Tutor at Queen Alexandra Hospital, training first-year trainees in cataract surgery, laser photocoagulation, and intravitreal injection procedures. He also instructs foundation year doctors in fundoscopy and supervises GP trainees seeking a sub-specialty interest in ophthalmology. He remains an integral member of the research team investigating diabetic maculopathy and AMD.